Equities

Firebrick Pharma Ltd

FRE:ASX

Firebrick Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.056
  • Today's Change0.00 / 0.00%
  • Shares traded14.52k
  • 1 Year change+12.00%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in AUDView more

In 2024, cash reserves at Firebrick Pharma Ltd fell by 1.53m. Cash Flow from Financing totalled 815.21k or 5,614.39% of revenues. In addition the company used 2.34m for operations while cash used for investing totalled 130.00.
Cash flow per share-0.0065
Price/Cash flow per share--
Book value per share0.012
Tangible book value per share0.012
More ▼

Balance sheet in AUDView more

Firebrick Pharma Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio7.19
Quick ratio6.36
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.